Infections and Microbial Types in Neonatal Sepsis: Literature Review
DOI:
https://doi.org/10.53089/medula.v14i7.1258Keywords:
antibiotic therapy, early onset sepsis, family education, late-onset sepsis, neonatal infection, neonatal sepsisAbstract
Neonatal sepsis is a systemic infection that involves the entire bloodstream and organs of newborns, making it one of the leading causes of neonatal morbidity and mortality, particularly in low- and middle-income countries. Neonatal sepsis is classified into early-onset sepsis (EOS) and late-onset sepsis (LOS), with varying etiologies involving gram-positive bacteria, gram-negative bacteria, and fungi. This article aims to provide a comprehensive review of the etiology, risk factors, diagnosis, and management of neonatal sepsis using an evidence-based approach. This article is based on an analysis of current literature relevant to the epidemiology, pathogenesis, and treatment of neonatal sepsis. EOS is primarily caused by vertical transmission of infection during delivery, with Group B Streptococcus (GBS) as the leading cause, while LOS is often associated with nosocomial infections caused by Staphylococcus epidermidis. Risk factors include prematurity, low birth weight, invasive procedures, and poor infection control. Management involves the administration of broad-spectrum empirical antibiotics within one hour of suspected sepsis, tailored to culture results. A holistic approach, including NICU care, family education, and optimization of infection prevention, has been shown to effectively reduce morbidity and mortality. Neonatal sepsis remains a significant challenge in perinatology, necessitating comprehensive management with an evidence-based approach encompassing timely antibiotic therapy, nosocomial infection control, and family education to improve neonatal outcomes. Preventive efforts, such as enhancing perinatal hygiene and neonatal care, must be optimized to reduce the incidence of neonatal sepsis.
References
Schrag SJ, et al. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36.
World Health Organization. Neonatal sepsis: global estimates and challenges. Geneva: WHO; 2019.
Simonsen KA, et al. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27(1):21-47.
Kliegman RM, et al. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier; 2020.
Shane AL, et al. A contemporary review of the epidemiology and management of neonatal sepsis. Clin Perinatol. 2017;44(1):1-17.
Gomella TL, et al. Neonatology: Management, Procedures, On-Call Problems, Diseases, and Drugs. 8th ed. New York: McGraw Hill; 2020.
van den Hoogen A, et al. Pathogenesis of neonatal sepsis. Pediatr Res. 2020;88(1):136-48.
Polin RA. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129(5):1006-15.
Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2011;122(1):78-86.
National Institute for Health and Care Excellence (NICE). Neonatal infection: antibiotics for prevention and treatment. NICE Guideline (NG195). 2021.
Bizzarro MJ, et al. Nosocomial sepsis in neonates: a case-control study. Pediatrics. 2005;116(5):13-21.
Okomo U, et al. Aetiology of invasive bacterial infection and antibiotic resistance in neonates in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2019;19(1):1219-34.
Faber J, et al. Neonatal sepsis: a serious threat to newborn survival. J Perinat Med. 2019;47(2):259-70.
Shane AL, et al. Group B Streptococcal disease in neonates and young infants. Clin Infect Dis. 2017;65(2):S89-S95.
Verani JR, et al. Prevention of perinatal group B streptococcal disease: revised guidelines. Pediatrics. 2010;125(5):123-30.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.